Schimke immunoosseous dysplasia (SIOD) is characterized by spondyloepiphyseal dysplasia (SED) resulting in short stature, nephropathy, and T-cell deficiency. Radiographic manifestations of SED include ovoid and mildly flattened vertebral bodies, small ilia with shallow dysplastic acetabular fossae, and small deformed capital femoral epiphyses. Nearly all affected individuals have progressive steroid-resistant nephropathy, usually developing within five years of the diagnosis of growth failure and terminating with end-stage renal disease. The majority of tested individuals have T-cell deficiency and an associated risk for opportunistic infection, a common cause of death. SIOD involves a spectrum that ranges from an infantile or severe early-onset form with a greater risk of death during childhood to a juvenile or milder later-onset form with likely survival into adulthood if renal disease is appropriately treated.

Any autosomal agammaglobulinemia in which the cause of the disease is a mutation in the CD79B gene.

Any autosomal agammaglobulinemia in which the cause of the disease is a mutation in the IGLL1 gene.

Any autosomal agammaglobulinemia in which the cause of the disease is a mutation in the CD79A gene.

Any autosomal agammaglobulinemia in which the cause of the disease is a mutation in the BLNK gene.

Any autosomal agammaglobulinemia in which the cause of the disease is a mutation in the PIK3R1 gene.